Claiborne; Christopher F.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Claiborne; Christopher F..The latest application filed is for "compounds and methods for inhibiting mitotic progression".
Company Profile
5.28.32
- Claiborne; Christopher F. - Binningen CH
- Claiborne; Christopher F. - Cambridge MA US
- Claiborne, Christopher F - Cambridge MA
- Claiborne; Christopher F. - Lansdale PA
Patent Activity
| Patent | Date |
|---|---|
| Compounds And Methods For Inhibiting Mitotic Progression App 20220041605 - Claiborne; Christopher F. ; et al. | 2022-02-10 |
| Aurora Kinase Inhibitors For Inhibiting Mitotic Progression App 20210214361 - Claiborne; Christopher F. ; et al. | 2021-07-15 |
| Compounds and methods for inhibiting mitotic progression Grant 11,014,928 - Claiborne , et al. May 25, 2 | 2021-05-25 |
| Aurora kinase inhibitors for inhibiting mitotic progression Grant 10,836,766 - Claiborne , et al. November 17, 2 | 2020-11-17 |
| Compounds And Methods For Inhibiting Mitotic Progression App 20200247810 - Kind Code | 2020-08-06 |
| Compounds and methods for inhibiting mitotic progression Grant 10,414,770 - Claiborne , et al. Sept | 2019-09-17 |
| Aurora Kinase Inhibitors For Inhibiting Mitotic Progression App 20190031662 - Claiborne; Christopher F. ; et al. | 2019-01-31 |
| Aurora kinase inhibitors for inhibiting mitotic progression Grant 9,988,384 - Claiborne , et al. June 5, 2 | 2018-06-05 |
| Compounds And Methods For Inhibiting Mitotic Progression App 20180134716 - Claiborne; Christopher F. ; et al. | 2018-05-17 |
| Compounds and methods for inhibiting mitotic progression Grant 9,765,078 - Claiborne , et al. September 19, 2 | 2017-09-19 |
| Aurora kinase inhibitors for inhibiting mitotic progression Grant 9,765,076 - Claiborne , et al. September 19, 2 | 2017-09-19 |
| Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 9,718,788 - Claiborne , et al. August 1, 2 | 2017-08-01 |
| Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20170050935 - CLAIBORNE; Christopher F. ; et al. | 2017-02-23 |
| Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 9,458,108 - Claiborne , et al. October 4, 2 | 2016-10-04 |
| Compounds And Methods For Inhibiting Mitotic Progression App 20160185782 - Claiborne; Christopher F. ; et al. | 2016-06-30 |
| Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20160039761 - CLAIBORNE; Christopher F. ; et al. | 2016-02-11 |
| Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 9,150,525 - Claiborne , et al. October 6, 2 | 2015-10-06 |
| Compounds and methods for inhibiting mitotic progression Grant 9,102,678 - Claiborne , et al. August 11, 2 | 2015-08-11 |
| Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20150183753 - Claiborne; Christopher F. ; et al. | 2015-07-02 |
| Aurora Kinase Inhibitors for Inhibiting Mitotic Progression App 20150166545 - Claiborne; Christopher F. ; et al. | 2015-06-18 |
| Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20140303193 - Claiborne; Christopher F. ; et al. | 2014-10-09 |
| Compounds And Methods For Inhibiting Mitotic Progression App 20140046055 - Claiborne; Christopher F. ; et al. | 2014-02-13 |
| Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20130345242 - Claiborne; Christopher F. ; et al. | 2013-12-26 |
| Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 8,481,550 - Claiborne , et al. July 9, 2 | 2013-07-09 |
| Lactam Compounds Useful As Protein Kinase Inhibitors App 20120178739 - Blackburn; Christopher ; et al. | 2012-07-12 |
| Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20120071482 - Claiborne; Christopher F. ; et al. | 2012-03-22 |
| Aurora Kinase Inhibitors For Inhibiting Mitotic Progression App 20110312942 - Claiborne; Christopher F. ; et al. | 2011-12-22 |
| Aurora Kinase Inhibitors For Inhibiting Mitotic Progression App 20110312943 - Claiborne; Christopher F. ; et al. | 2011-12-22 |
| Aurora kinase inhibitors for inhibiting mitotic progression Grant 8,026,246 - Claiborne , et al. September 27, 2 | 2011-09-27 |
| Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 8,008,307 - Claiborne , et al. August 30, 2 | 2011-08-30 |
| Lactam compounds useful as protein kinase inhibitors Grant 7,935,694 - Blackburn , et al. May 3, 2 | 2011-05-03 |
| Lactam Compounds Useful As Protein Kinase Inhibitors App 20110039820 - Blackburn; Christopher ; et al. | 2011-02-17 |
| Pyridobenzazepine compounds and methods for inhibiting mitotic progression Grant 7,718,648 - Claiborne , et al. May 18, 2 | 2010-05-18 |
| Compounds And Methods For Inhibiting Mitotic Progression App 20090299060 - Claiborne; Christopher F. ; et al. | 2009-12-03 |
| 3-fluoro-piperidines as NMDA/NR2B antagonists Grant 7,592,360 - Liverton , et al. September 22, 2 | 2009-09-22 |
| Compounds and methods for inhibiting mitotic progression Grant 7,572,784 - Claiborne , et al. August 11, 2 | 2009-08-11 |
| Lactam compounds useful as protein kinase inhibitors App 20090105213 - Blackburn; Christopher ; et al. | 2009-04-23 |
| Lactam compounds useful as protein kinase inhibitors Grant 7,459,448 - Blackburn , et al. December 2, 2 | 2008-12-02 |
| Melanocortin-4 receptor binding compounds and methods of use thereof App 20080269217 - Vos; Tricia J. ; et al. | 2008-10-30 |
| Compounds for inhibiting mitotic progression App 20080167292 - Claiborne; Christopher F. ; et al. | 2008-07-10 |
| Melanocortin-4 receptor binding compounds and methods of use thereof Grant 7,375,125 - Vos , et al. May 20, 2 | 2008-05-20 |
| Heteroaryl compounds useful as inhibitors of E1 activating enzymes App 20080051404 - Claiborne; Christopher F. ; et al. | 2008-02-28 |
| Pyridobenzazepine compounds and methods for inhibiting mitotic progression App 20080045501 - Claiborne; Christopher F. ; et al. | 2008-02-21 |
| N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists Grant 7,259,157 - Liverton , et al. August 21, 2 | 2007-08-21 |
| N-substituted nonaryl-heterocyclic nmda/nr2b antagonists App 20070149568 - Liverton; NigelJ ; et al. | 2007-06-28 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Grant 7,217,716 - Claiborne , et al. May 15, 2 | 2007-05-15 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Grant 7,053,089 - Claiborne , et al. May 30, 2 | 2006-05-30 |
| Lactam compounds useful as protein kinase inhibitors App 20060100194 - Blackburn; Christopher ; et al. | 2006-05-11 |
| Compounds and methods for inhibiting mitotic progression App 20050256102 - Claiborne, Christopher F. ; et al. | 2005-11-17 |
| N-substituted nonaryl-heterocyclic nmda/nr2b antagonists App 20040209889 - Claiborne, Christopher F ; et al. | 2004-10-21 |
| Substituted imidazoles having cytokine inhibitory activity Grant 6,767,908 - Claiborne , et al. July 27, 2 | 2004-07-27 |
| Melanocortin-4 receptor binding compounds and methods of use thereof App 20040082779 - Vos, Tricia J. ; et al. | 2004-04-29 |
| Carbocyclic potassium channel inhibitors Grant 6,632,836 - Baker , et al. October 14, 2 | 2003-10-14 |
| N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists App 20030119811 - Liverton, Nigel J. ; et al. | 2003-06-26 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists App 20020165241 - Claiborne, Christopher F. ; et al. | 2002-11-07 |
| Substituted imidazoles having cytokine inhibitory activity App 20020026056 - Claiborne, Christopher F. ; et al. | 2002-02-28 |
| 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists Grant 6,316,474 - McCauley , et al. November 13, 2 | 2001-11-13 |
| Substituted imidazoles having cytokine inhibitory activity Grant 6,207,687 - Claiborne , et al. March 27, 2 | 2001-03-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 